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SUMMARY
Chromoblastomycosis (CBM) is a chronic subcutaneous infection caused by several dematiaceous fungi. The most commonly
etiological agent found in Brazil is Fonsecaea pedrosoi, which appears as thick walled, brownish colored cells with transverse and
longitudinal division in the lesions, called “muriform cells”. This disease is found worldwide but countries like Madagascar and
Brazil have highest incidence. Diagnosis is made by clinical, direct and histopathologic examination and culture of specimens.
Serological tests have been used to identify specific antibodies against Fonsecaea pedrosoi antigens, as well as immunotechniques
have been used for CBM serological identification and diagnosis. In the present study double immunodiffusion (DID),
counterimmunoelectrophoresis (CIE) and immunoenzymatic test (ELISA) have been used to evaluate humoral immune response in
patients with CBM caused by F. pedrosoi. Metabolic antigen was used for immunoprecipitation tests (DID and CIE) while somatic
antigen for ELISA. Our results demonstrated 53% sensitivity and 96% specificity for DID, while CIE presented 68% sensitivity and
90.5% specificity. ELISA demonstrated 78% sensibility and 83% specificity. Serological tests can be a useful tool to study different
aspects of CBM, such as helping differential diagnosis, when culture of the pathogenic agent is impossible.
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INTRODUCTION
Chromoblastomycosis (CBM) is a chronic infection of skin and
subcutaneous tissue caused by dematiaceous fungi. The causal agents
are normally found as saphrophytes in soil and vegetation and infection
follows traumatic implantation17.
The most important agent of CBM in Brazil is Fonsecaea pedrosoi.
It can be considered endemic in certain regions1,3,4,13,22,24,27,28,29,30. Diagnosis
is accomplished by clinical, direct and histopathologic examination and
culture of specimens. The fungus appears in lesions as thick walled,
brownish colored cells with transverse and longitudinal division, also
known as “muriform cells” or “sclerotic cells” 17.
Although serological tests are of great help in establishing diagnosis
and helping monitorization of therapy of deep mycoses, they have not
been routinely used for CBM. The first demonstration of specific
circulating antibodies in F. pedrosoi-caused CBM was performed using
conidia precipitation5. DID and CIE were used to analyze sera of CBM
caused by Cladophialophora carrionii. It was demonstrated that
metabolic antigens presented higher specificity and results depended on
the use of fresh sera, since storage for long period (two years) causes
looses or inactivation of the antibodies. These authors recommended
the implantation of this methodology for routine immunodiagnosis of
chromoblastomycosis based on the results and on the ease to perform
the tests32,33.
The exoantigen test was used for serological identification of several
dematiaceous fungi and it is considered a useful tool to distinguish CBM
agents8,13,21,23.
The ELISA has been extensively used to detect either antigens or
antibodies in infectious diseases. Investigators from Madagascar2,9
reported the successful use of ELISA to study sera from human CBM
cases, most of which caused by F. pedrosoi. They reported that ELISA
test was reproducible, gave satisfactory results and allowed biologic
diagnosis of CBM, even when culture of the pathogenic agent was not
possible. ELISA, using somatic antigen from F. pedrosoi and C. carrionii
reference strains, presented 87% sensitivity and 92.3% specificity. The
same test was used to detect circulating antibodies in patients with C.
carrionii-caused CBM. This test proved to be a useful tool for the
differential serodiagnosis of this infection.
In the present study, the authors evaluated sensitivity and specificity
of DID, CIE and ELISA in detecting anti- F. pedrosoi antibodies in sera
of patients with CBM caused by this fungus.
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MATERIAL AND METHODS
Sera: Sixty sera samples obtained from patients with CBM caused
by F. pedrosoi and followed at the “Clínica Dermatológica do Hospital
das Clínicas da Universidade de São Paulo, Brasil” were analyzed.
Diagnosis was confirmed by the presence of sclerotic cells in lesions
(direct exam) and growth of F. pedrosoi in culture. Hyperimmune serum
was produced by inoculation of two New Zealand males, 3 kg in weight
rabbits with F. pedrosoi metabolic antigen, according to GARCIA et
al.12. Serum was precipitated by caprilic acid according to the
methodology described by McKINNEY & PARKINSON20. Sera from
36 sporothricosis (SPT) patients, 34 cutaneous leishmaniasis (CL)
patients and 48 from healthy blood donors (HBD) were used as controls.
Metabolic Antigen (Met-Ag): Culture filtrate of F. pedrosoi sample
# 884 from Instituto de Medicina Tropical de São Paulo Collection was
used to produce Met-Ag. This sample was cultured on Sabouraud-agar
at 25 ºC for 10 days. The inoculum was prepared in 0.85% saline, to
reach McFarland´s scale 5. Five ml of the suspension was incubated in
250 ml of Sabouraud-broth at 25 ºC for 30 days, under constant shaking.
Culture was killed by addition of thimerosal at 1:5000 and filtrated
through Whatman paper #1, according to VIDAL et al. 31. The filtrate
was concentrated (antigen) and maintained at 4 ºC until use.
Somatic antigen (Som-Ag): Mycelial mats were washed in phosphate
buffer solution (PBS) three times and mechanically disrupted using ice
and glass bits. The suspension was left at 4 ºC for two days followed by
centrifuging at 3000 rpm for 30 minutes, according to GARCIA11. The
supernatant (antigen) was frozen at –20 ºC until use.
Antigen protein content was determined according to LOWRY et
al.19.
Double immunodiffusion (DID): Glass slides (25 X 75 mm) were
covered with 3 ml of sodium citrate agar 1% and left at 4 ºC for three
hours. A seven-well template was stamped twice on the surface of each
slide. Met-Ag was placed in the central well and sera samples in the
surrounding six wells. The slides were incubated for 48 hours at room
temperature and washed for further 48 hours using saline solution. A
stove was used to dry the slides by evaporation. Slides were stained
using 0.4% Coomassie Brilliant Blue (Sigma) in acetic acid 10% solution.
Precipitation lines indicated positivity.
Counterimmunoelectrophoresis (CIE): The same slides used for
DID were covered with barbital-buffered agarose (pH 8.2), to produce
wells with 3 mm in depth. Thirteen µl of Met-Ag and sera were placed
in the wells. The slides were submitted to electrophoresis with barbital
buffer (pH 8.2), 4 volts/cm, for 90 minutes through filter paper. Gels
were processed as described for DID.
ELISA: Indirect ELISA was performed according to DEL NEGRO
et al.7. For standardization purposes different aspects were evaluated: a)
Antigen concentration: Somatic antigen optimal protein concentration
was found to be 2.5 µg/ml, as demonstrated by dilution in carbonate/
bicarbonate buffer (pH 9.6); b) both positive and negative sera were
used at 1:40 dilution (previously titrated) and each sample was analyzed
in triplicate; c) Conjugate: a goat anti-human (reactive against IgG)
peroxidase conjugate (Sigma) was diluted 1:700 (optimal concentration).
Each experiment was performed including a step with 1% Bovine Serum
Albumine (BSA). Optical density (OD) was determined using a 490 nm
filter. Cut off value was determined as the average OD of control sera
added two standard deviations. d) Sensitivity and specificity were
calculated on homologous (60 CBM) and heterologous (36 SPT, 34 CL
and 48 HBD) sera samples, according to LINNET18.
RESULTS
Hyperimmune serum reacted both with Met-Ag by DID and CIE up
to a 1:32 dilution. Met-Ag protein content was 4.90 mg/ml while for
Som-Ag it was 0.70 mg/ml. Hyperimmune serum showed 0.186 mg/ml
protein content.
DID: 32 (53%) out of 60 CBM sera samples tested positive. Only 3
(8.3%) of 36 SPT sera and 3 (8.8%) out 34 CL sera tested positive.
None of the 48 HBD sera tested positive. DID presented 53% sensitivity
and 96% specificity.
CIE: 41 (68%) out of 60 CBM sera samples tested positive. Six
(16.7%) out of 36 SPT sera, 6 (17.6%) out of 34 CL sera tested positive
exclusively when undiluted sera samples were used. None of 48 HBD
sera tested positive. CIE presented 68% sensitivity and 90.5% specificity.
Table 1 describes all values of sensitivity and specificity of the different
tests, against the all sera sample groups studied.
ELISA: Figure 1 demonstrates results about ELISA. Cut-off value
was determined as 0.122 OD (black line). ELISA tested positive in 45
CBM sera, 10 SPT sera, 8 CL sera and 3 HBD sera. This test showed
78% of sensitivity and 83% of specificity.
DISCUSSION
Although serological tests are not routinely used for CBM diagnosis,
numerous papers on this matter have appeared in the literature. A wide
array of different dematiaceous fungi antigens is currently available for
use in serologic tests 2,3,5,6,9,10,14,16,24,28,29. The large experience using Met-
Ag in gel precipitation serologic tests for diagnosis of deep mycosis led
us to test this type of antigen using DID and CIE. BUCKEY &
MURRAY5, testing CBM Met-Ag by DID, demonstrated that almost all
patients developed precipitating antibodies at some phase of the disease.
Table 1
Sensitivity and specificity results by tests
Reaction Sensitivity Specificity







*number of reagent sera / total number sera used. CBM = chromoblastomycosis;
SPT = sporotricosis; CL = leishmaniasis; HBD = health blood donors; DID =
double immunodiffusion; CIE = couterimmunoelectrophoresis.
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VILLALBA & YEGRES33 emphasized that precipitation reactions
tend to present low sensitivity because of the low amount of circulating
antibodies found in CBM. These authors also reported cross-reactivity
with health controls’ sera and SPT patients’ sera, which accounted for
low specificity, a finding also observed by ISHIZAKI et al.15, who studied
hyperimmune anti-Sporothrix schenckii serum against different fungal
antigens, including F. pedrosoi. VILLALBA32 testing Met-Ag by CIE
demonstrated that this antigen presented higher specificity for F. pedrosoi
than Som-Ag. ROMERO et al.26 evaluated sera samples of patients with
CBM caused by Cladophialophora carrionii using DID and CIE.
According to these authors DID presented higher specificity and
sensitivity than CIE. In contrast, the present data showed that CIE
presented superior sensitivity, but lower specificity.
In the present study ELISA was able to identify specific antibodies
against F. pedrosoi Som-Ag in 45 (75%) of 60 CBM sera. It was 78%
sensitive and 83% specific. In 1993, ANDRIANTSIMAHAVANDY et
al.2 used ELISA to test sera of CBM patients from Madagascar. The
authors used Som-Ag of both, F. pedrosoi and C. carrionii, the most
prevalent species in the island. Based on 86% reproducibility and 65%
specificity they concluded that ELISA, using F. pedrosoi and C. carrionii
Som-Ag, was a satisfactory tool for biologic diagnosis of CBM.
ESTERRE et al.9 used ELISA to analyse 136 sera samples obtained
from 43 CBM patients enrolled in a one-year therapeutic trial of
terbinafine. Sensitivity reached 87% and specificity 92.3%. ROMERO
et al.27 evaluated ELISA test for CBM caused by C. carrionii in Venezuela
using Som-Ag. Results were also encouraging (82.5% sensitivity and
81.8% specificity).
The data presented demonstrate that serological tests can be a useful
tool to study CBM caused by F. pedrosoi specially when the culture of
the pathogenic agent is not possible and on the basis of the results, the
serological tests can be a useful tool to help a serological identification,
immunological evaluate and monitoring the efficiency of treatment on
CBM, after future studies. The identification of specific antigenic
fractions is currently under investigation and results are promising.
RESUMO
Técnicas de imunoprecipitação e ELISA na detecção de anticorpos
anti-Fonsecaea pedrosoi na cromoblastomicose
Cromoblastomicose (CBM) é infecção subcutânea causada por vários
fungos demáceos. O agente mais importante no Brasil é Fonsecaea
pedrosoi, que se apresenta nas lesões como células de coloração
acastanhada, com divisão transversal e longitudinal, originando as
denominadas “células muriformes”. Esta infecção apresenta caráter
universal, mas países como Madagascar e Brasil apresentam alta
incidência. O diagnóstico é realizado através dos exames clínico, direto
e histopatológico, acompanhado de cultura e identificação do agente
etiológico. Os testes sorológicos foram aplicados para identificar
anticorpos específicos frente a antígenos de Fonsecaea pedrosoi e várias
metodologias têm sido empregadas para identificação sorológica e o
diagnóstico da CBM. Neste estudo, avaliamos reações de imunodifusão
dupla (DID), contraimunoeletroforese (CIE) e teste imunoenzimático
(ELISA) para avaliar a resposta imune humoral na CBM causada por F.
pedrosoi. Utilizamos antígeno metabólico para DID e CIE e antígeno
somático para ELISA. Nossos dados revelaram 53% e 68% de
sensibilidade e 96% e 90,5% de especificidade, respectivamente. O teste
de ELISA demonstrou 78% de sensibilidade e 83% de especificidade.
Estes resultados indicam que as reações sorológicas podem ser uma
ferramenta útil no auxílio diagnóstico desta infecção, quando a cultura
do agente não for possível.
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